Registro:

Referencias:

• Lanier, L.L., Evolutionary struggles between NK cells and viruses (2008) Nat. Rev. Immunol., 8, pp. 259-268
• Moretta, L., Bottino, C., Pende, D., Castriconi, R., Mingari, M.C., Moretta, A., Surface NK receptors and their ligands on tumor cells (2006) Semin. Immunol., 18, pp. 151-158
• Zwirner, N.W., Domaica, C.I., Cytokine regulation of natural killer cell effector functions (2010) Biofactors, 36, pp. 274-288
• Ziblat, A., Domaica, C.I., Spallanzani, R.G., Iraolagoitia, X.L., Rossi, L.E., Avila, D.E., Torres, N.I., Zwirner, N.W., IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness (2015) Eur. J. Immunol., 45, pp. 192-202
• Girart, M.V., Fuertes, M.B., Domaica, C.I., Rossi, L.E., Zwirner, N.W., Engagement of TLR3, TLR7, and NKG2D regulate IFN-γamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12 (2007) J. Immunol., 179, pp. 3472-3479
• Lanier, L.L., Up on the tightrope: Natural killer cell activation and inhibition (2008) Nat. Immunol., 9, pp. 495-502
• Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S., Functions of natural killer cells (2008) Nat. Immunol., 9, pp. 503-510
• Vivier, E., Raulet, D.H., Moretta, A., Caligiuri, M.A., Zitvogel, L., Lanier, L.L., Yokoyama, W.M., Ugolini, S., Innate or adaptive immunity? the example of natural killer cells (2011) Science, 331, pp. 44-49
• Moretta, A., Marcenaro, E., Sivori, S., Della Chiesa, M., Vitale, M., Moretta, L., Early liaisons between cells of the innate immune system in inflamed peripheral tissues (2005) Trends Immunol., 26, pp. 668-675
• Walzer, T., Dalod, M., Robbins, S.H., Zitvogel, L., Vivier, E., Naturalkiller cells and dendritic cells: L'union fait la force (2005) Blood, 106, pp. 2252-2258
• Martín-Fontecha, A., Thomsen, L.L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., Sallusto, F., Induced recruitment of NK cells to lymph nodes provides IFN-γamma for T(H)1 priming (2004) Nat. Immunol., 5, pp. 1260-1265
• Cook, K.D., Whitmire, J.K., The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection (2013) J. Immunol., 190, pp. 641-649
• Schuster, I.S., Wikstrom, M.E., Brizard, G., Coudert, J.D., Estcourt, M.J., Manzur, M., O'Reilly, L.A., Hill, G.R., TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity (2014) Immunity, 41, pp. 646-656
• Lang, P.A., Lang, K.S., Xu, H.C., Grusdat, M., Parish, I.A., Recher, M., Elford, A.R., Tran, C.W., Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity (2012) Proc. Natl. Acad. Sci. USA, 109, pp. 1210-1215
• Waggoner, S.N., Taniguchi, R.T., Mathew, P.A., Kumar, V., Welsh, R.M., Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis (2010) J. Clin. Invest., 120, pp. 1925-1938
• Laffont, S., Seillet, C., Ortaldo, J., Coudert, J.D., Guéry, J.C., Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells (2008) Blood, 112, pp. 661-671
• Ehlers, M., Papewalis, C., Stenzel, W., Jacobs, B., Meyer, K.L., Deenen, R., Willenberg, H.S., Scherbaum, W.A., Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice (2012) Endocrinology, 153, pp. 4367-4379
• Rabinovich, B.A., Li, J., Shannon, J., Hurren, R., Chalupny, J., Cosman, D., Miller, R.G., Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells (2003) J. Immunol., 170, pp. 3572-3576
• Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L., Santoni, A., Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis (2007) Blood, 110, pp. 606-615
• Soderquest, K., Walzer, T., Zafirova, B., Klavinskis, L.S., Polić, B., Vivier, E., Lord, G.M., Martín-Fontecha, A., Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses (2011) J. Immunol., 186, pp. 3304-3308
• Peppa, D., Gill, U.S., Reynolds, G., Easom, N.J., Pallett, L.J., Schurich, A., Micco, L., Adams, D.H., Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion (2013) J. Exp. Med., 210, pp. 99-114
• Lu, L., Ikizawa, K., Hu, D., Werneck, M.B., Wucherpfennig, K.W., Cantor, H., Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway (2007) Immunity, 26, pp. 593-604
• Waggoner, S.N., Cornberg, M., Selin, L.K., Welsh, R.M., Natural killer cells act as rheostats modulating antiviral T cells (2011) Nature, 481, pp. 394-398
• Andrews, D.M., Estcourt, M.J., Andoniou, C.E., Wikstrom, M.E., Khong, A., Voigt, V., Fleming, P., Van Der Most, R.G., Innate immunity defines the capacity of antiviral T cells to limit persistent infection (2010) J. Exp. Med., 207, pp. 1333-1343
• Hayakawa, Y., Screpanti, V., Yagita, H., Grandien, A., Ljunggren, H.G., Smyth, M.J., Chambers, B.J., NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy (2004) J. Immunol., 172, pp. 123-129
• Gajewski, T.F., Schreiber, H., Fu, Y.X., Innate and adaptive immune cells in the tumor microenvironment (2013) Nat. Immunol., 14, pp. 1014-1022
• Rabinovich, G.A., Gabrilovich, D., Sotomayor, E.M., Immunosuppressive strategies that are mediated by tumor cells (2007) Annu. Rev. Immunol., 25, pp. 267-296
• Blank, C., Gajewski, T.F., Mackensen, A., Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: Implications for tumor immunotherapy (2005) Cancer Immunol. Immunother., 54, pp. 307-314
• Park, S.J., Namkoong, H., Doh, J., Choi, J.C., Yang, B.G., Park, Y., Chul Sung, Y., Negative role of inducible PD-1 on survival of activated dendritic cells (2014) J. Leukoc. Biol., 95, pp. 621-629
• Driessens, G., Kline, J., Gajewski, T.F., Costimulatory and coinhibitory receptors in anti-tumor immunity (2009) Immunol. Rev., 229, pp. 126-144
• Mahoney, K.M., Freeman, G.J., McDermott, D.F., The next immunecheckpoint inhibitors: PD-1/PD-L1 blockade in melanoma (2015) Clin. Ther., 37, pp. 764-782
• Herbst, R.S., Soria, J.C., Kowanetz, M., Fine, G.D., Hamid, O., Gordon, M.S., Sosman, J.A., Gettinger, S.N., Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (2014) Nature, 515, pp. 563-567
• Teng, M.W., Ngiow, S.F., Ribas, A., Smyth, M.J., Classifying cancers based on T-cell infiltration and PD-L1 (2015) Cancer Res., 75, pp. 2139-2145
• Zhang, B., Bowerman, N.A., Salama, J.K., Schmidt, H., Spiotto, M.T., Schietinger, A., Yu, P., Rowley, D.A., Induced sensitization of tumor stroma leads to eradication of established cancer by T cells (2007) J. Exp. Med., 204, pp. 49-55
• Rossi, L.E., Avila, D.E., Spallanzani, R.G., Ziblat, A., Fuertes, M.B., Lapyckyj, L., Croci, D.O., Zwirner, N.W., Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression (2012) J. Leukoc. Biol., 91, pp. 321-331
• Joshi, N.S., Cui, W., Chandele, A., Lee, H.K., Urso, D.R., Hagman, J., Gapin, L., Kaech, S.M., Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor (2007) Immunity, 27, pp. 281-295
• Sallusto, F., Geginat, J., Lanzavecchia, A., Central memory and effector memory T cell subsets: Function, generation, and maintenance (2004) Annu. Rev. Immunol., 22, pp. 745-763
• Deniz, G., Erten, G., Kucuksezer, U.C., Kocacik, D., Karagiannidis, C., Aktas, E., Akdis, C.A., Akdis, M., Regulatory NK cells suppress antigen-specific T cell responses (2008) J. Immunol., 180, pp. 850-857
• Mailloux, A.W., Young, M.R., NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment (2009) J. Immunol., 182, pp. 2753-2765
• Youn, J.I., Gabrilovich, D.I., The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity (2010) Eur. J. Immunol., 40, pp. 2969-2975
• Park, Y.J., Song, B., Kim, Y.S., Kim, E.K., Lee, J.M., Lee, G.E., Kim, J.O., Kang, C.Y., Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells (2013) Cancer Res., 73, pp. 5669-5681
• Fuertes, M.B., Kacha, A.K., Kline, J., Woo, S.R., Kranz, D.M., Murphy, K.M., Gajewski, T.F., Host type i IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells (2011) J. Exp. Med., 208, pp. 2005-2016
• Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E., Walzer, T., Maturation of mouse NK cells is a 4-stage developmental program (2009) Blood, 113, pp. 5488-5496
• Robbins, S.H., Nguyen, K.B., Takahashi, N., Mikayama, T., Biron, C.A., Brossay, L., Cutting edge: Inhibitory functions of the killer cell lectin-like receptor G1 molecule during the activation of mouse NK cells (2002) J. Immunol., 168, pp. 2585-2589
• Omi, A., Enomoto, Y., Kiniwa, T., Miyata, N., Miyajima, A., Mature resting Ly6C(high) natural killer cells can be reactivated by IL-15 (2014) Eur. J. Immunol., 44, pp. 2638-2647
• Stojanovic, A., Fiegler, N., Brunner-Weinzierl, M., Cerwenka, A., CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells (2014) J. Immunol., 192, pp. 4184-4191
• Koebel, C.M., Vermi, W., Swann, J.B., Zerafa, N., Rodig, S.J., Old, L.J., Smyth, M.J., Schreiber, R.D., Adaptive immunity maintains occult cancer in an equilibrium state (2007) Nature, 450, pp. 903-907
• Fogel, L.A., Yokoyama, W.M., French, A.R., Natural killer cells in human autoimmune disorders (2013) Arthritis Res. Ther., 15, p. 216
• Brahmer, J.R., Tykodi, S.S., Chow, L.Q., Hwu, W.J., Topalian, S.L., Hwu, P., Drake, C.G., Odunsi, K., Safety and activity of anti-PD-L1 antibody in patients with advanced cancer (2012) N. Engl. J. Med., 366, pp. 2455-2465
• Dong, H., Strome, S.E., Salomao, D.R., Tamura, H., Hirano, F., Flies, D.B., Roche, P.C., Tamada, K., Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion (2002) Nat. Med., 8, pp. 793-800
• Terme, M., Ullrich, E., Aymeric, L., Meinhardt, K., Coudert, J.D., Desbois, M., Ghiringhelli, F., Yagita, H., Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells (2012) Cancer Res., 72, pp. 2757-2767

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------